4.8 Article

Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in pancreatic ductal adenocarcinoma

Related references

Note: Only part of the references are listed.
Article Oncology

MUC16 Promotes Liver Metastasis of Pancreatic Ductal Adenocarcinoma by Upregulating NRP2-Associated Cell Adhesion

Saravanakumar Marimuthu et al.

Summary: This study aimed to identify the molecular mechanism of liver metastasis in pancreatic ductal adenocarcinoma (PDAC) mediated by MUC16. The expression of MUC16 was significantly high in PDAC tissues, PDAC organoids, and metastatic liver tissues, while no expression was observed in normal pancreatic tissues. MUC16 knockdown decreased the colony formation, migration, and endothelial/p-selectin binding in PDAC cells, while ectopic overexpression of MUC16-Cter increased colony formation and motility in pancreatic cancer cells. MUC16 promoted cell survival and colonization in the liver and enhanced liver metastasis in a mouse model. The integrated analyses suggested that MUC16 regulates NRP2 and induces metastasis in PDAC via the JAK2/STAT1 signaling pathway.

MOLECULAR CANCER RESEARCH (2022)

Article Biochemistry & Molecular Biology

Selective inhibition of stemness through EGFR/FOXA2/SOX9 axis reduces pancreatic cancer metastasis

Garima Kaushik et al.

Summary: Pancreatic cancer stem cells (PCSC) play a crucial role in metastasis and therapy resistance of pancreatic cancer. The combination treatment of afatinib with gemcitabine shows promising results in targeting PCSCs and reducing tumor growth and metastasis. This novel mechanism involving the EGFR/ERK/FOXA2/SOX9 axis may provide a tailored approach to enhance chemotherapy efficacy in various cancer types.

ONCOGENE (2021)

Review Biochemistry & Molecular Biology

Recent advances in organoid development and applications in disease modeling

Sanchita Rauth et al.

Summary: The development of three-dimensional organoid culture system, based on improved understanding of stem cell niches, organogenesis, and disease models, offers a promising approach for studying human diseases. This technological breakthrough has applications in metabolomics, drug development, infectious diseases, and gut microbiome research. In addition, organoids are also used in cancer modeling through high throughput sequencing approaches.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)

Review Gastroenterology & Hepatology

Harnessing metabolic dependencies in pancreatic cancers

Joel Encarnacion-Rosado et al.

Summary: PDAC is a highly aggressive cancer with unique tumor microenvironment, which can reprogram metabolism to adapt to the harsh conditions and develop therapeutic resistance. PDAC cells survive in the hostile environment by using non-canonical metabolic pathways and scavenging pathways.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Article Multidisciplinary Sciences

Suppression of pancreatic ductal adenocarcinoma growth and metastasis by fibrillar collagens produced selectively by tumor cells

Chenxi Tian et al.

Summary: The ECM of pancreatic ductal adenocarcinoma has partially uncleaved C-terminal prodomains of fibrillar collagens, indicating reduced procollagen C-proteinase activity. The enzyme BMP1 selectively suppresses tumor growth and metastasis in cells expressing high levels of COL1A1. Cancer-cell-derived fibrillar collagen plays a role in selectively restraining tumor growth.

NATURE COMMUNICATIONS (2021)

Article Gastroenterology & Hepatology

Pancreatic Tumor Microenvironment Factor Promotes Cancer Stemness via SPP1-CD44 Axis

Palanisamy Nallasamy et al.

Summary: The study revealed that CAFs promote stemness enrichment in PC through the osteopontin/secreted phosphoprotein 1-CD44 axis. Long-term treatment of PC cells with CAF-CM resulted in increased stemness characteristics, indicated by significantly higher levels of CSC markers and enhanced tumorsphere formation.

GASTROENTEROLOGY (2021)

Article Biochemistry & Molecular Biology

Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma

Rama Krishna Nimmakayala et al.

Summary: The study identified distinct subtypes of cancer stem cells (CSCs) in pancreatic ductal adenocarcinoma (PDAC) with specific metabolic and stemness signatures, which play a crucial role in organ-specific metastasis. Liver metastasis exhibited drug-resistant CSC- and EMT-like phenotype with glyco-oxidative metabolism, while lung metastasis displayed ALDH+/CD133+ and MET-like phenotype with oxidative metabolism.

ONCOGENE (2021)

Review Gastroenterology & Hepatology

Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer

Louis Buscail et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Review Gastroenterology & Hepatology

Pancreatic cancer stroma: an update on therapeutic targeting strategies

Abdel N. Hosein et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Review Biochemistry & Molecular Biology

Crosstalk between Tumor and Stromal Cells in Pancreatic Ductal Adenocarcinoma

Nadine Sperb et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Medicine, General & Internal

Pancreatic cancer

Jonathan D Mizrahi et al.

LANCET (2020)

Article Biochemistry & Molecular Biology

The glycoprotein mucin-1 negatively regulates GalNAc transferase 5 expression in pancreatic cancer

Thomas Caffrey et al.

FEBS LETTERS (2019)

Article Multidisciplinary Sciences

Proteomic analyses of ECM during pancreatic ductal adenocarcinoma progression reveal different contributions by tumor and stromal cells

Chenxi Tian et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Gastroenterology & Hepatology

Disruption of C1galt1 Gene Promotes Development and Metastasis of Pancreatic Adenocarcinomas in Mice

Seema Chugh et al.

GASTROENTEROLOGY (2018)

Article Immunology

Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer

Daniel Ohlund et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2017)

Article Oncology

MUC16 Regulates TSPYL5 for Lung Cancer Cell Growth and Chemoresistance by Suppressing p53

Imayavaramban Lakshmanan et al.

CLINICAL CANCER RESEARCH (2017)

Article Biochemistry & Molecular Biology

Organoid Models of Human and Mouse Ductal Pancreatic Cancer

Sylvia F. Boj et al.

Article Multidisciplinary Sciences

Whole genomes redefine the mutational landscape of pancreatic cancer

Nicola Waddell et al.

NATURE (2015)

Article Multidisciplinary Sciences

Membrane proximal ectodomain cleavage of MUC16 occurs in the acidifying Golgi/post-Golgi compartments

Srustidhar Das et al.

SCIENTIFIC REPORTS (2015)

Review Biochemistry & Molecular Biology

MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress

Mildred Felder et al.

MOLECULAR CANCER (2014)

Review Gastroenterology & Hepatology

Mucins in pancreatic cancer and its microenvironment

Sukhwinder Kaur et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)

Article Biochemistry & Molecular Biology

Mucin 16 is a functional selectin ligand on pancreatic cancer cells

Shih-Hsun Chen et al.

FASEB JOURNAL (2012)

Article Multidisciplinary Sciences

Pathobiological Implications of MUC16 Expression in Pancreatic Cancer

Dhanya Haridas et al.

PLOS ONE (2011)

Article Biochemistry & Molecular Biology

Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes

Jennifer A. Belisle et al.

MOLECULAR CANCER (2010)

Article Oncology

Pancreatic cancer cells resistance to gemcitabine: the role of MUC4 mucin

S. Bafna et al.

BRITISH JOURNAL OF CANCER (2009)

Article Multidisciplinary Sciences

CA125/MUC16 Is Dispensable for Mouse Development and Reproduction

Dong-Joo Cheon et al.

PLOS ONE (2009)